# Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments

> **NCT02284581** · — · UNKNOWN · sponsor: **Consorzio Oncotech** · enrollment: 10000 (estimated)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02284581
- **Lead sponsor:** Consorzio Oncotech
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2023-06
- **Final completion:** 2025-12
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2023-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02284581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02284581, "Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02284581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*